Reconstruction of a chicken BF2 protein complex and identification of binding nonamer peptides derived from avian influenza virus hemagglutinin

Veterinary Immunology and Immunopathology

Volumn 126, Issue 1-2, 2008, Pages 91-101

  Yan, Ruo Qian ^a,b   Wu, Zhi Ming ^a   Fang, Qin Mei ^b   Zhang, Zhi Ling ^a   Zhang, Jian ^a   Li, Xin Sheng ^b   Hao, Hui Fang ^b   Xia, Chun ^b  

^a Animal Husbandry Bureau of Henan Province   (China)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

AIV; BF2 protein complex; Chicken; Nonamer peptides; T cell epitopes

Indexed keywords

2 DIETHYLAMINOETHANOL; BETA 2 MICROGLOBULIN; BINDING PROTEIN; BLOOD CLOTTING FACTOR 10A PROTEASE; HYBRID PROTEIN; MYELIN BASIC PROTEIN; PROTEIN BF2; PROTEINASE; SEPHAROSE; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ;

AMINO ACID SEQUENCE; ARTICLE; CHICKEN; CHROMATOGRAPHY; CIRCULAR DICHROISM; COMPLEX FORMATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; ESCHERICHIA COLI; GENETIC LINKAGE; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H9N2; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PEPTIDE ANALYSIS; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PURIFICATION; PROTEIN SECONDARY STRUCTURE; TANDEM MASS SPECTROMETRY;

ANIMALS; CHICKENS; GENE EXPRESSION REGULATION; GENES, MHC CLASS I; HEMAGGLUTININS; IMMUNOGLOBULIN HEAVY CHAINS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA A VIRUS, H9N2 SUBTYPE; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS;

AVIAN INFLUENZA VIRUS;

EID: 54249097363     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.06.007     Document Type: Article

References (51)

1. Altman J.D., Moss P.A., Goulder P.J., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., McMichael A.J., and Davis M.M. Phenotypic analysis of antigen-specific T lymphocytes. Science 274 (1996) 94-96
2. Bjorkman P.J., and Parham P. Structure, function, and diversity of class I major histocompatibility complex molecules. Annu. Rev. Biochem. 59 (1990) 253-288
3. Bonner P.L., Lill J.R., Hill S., Creaser C.S., and Rees R.C. Electrospray mass spectrometry for the identification of MHC class I-associated peptides expressed on cancer cells. J. Immunol. Methods 262 (2002) 5-19
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
5. Chen Y.H., Yang J.T., and Martinez H.M. Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion. Biochemistry 11 (1972) 4120-4131
6. Coles R.M., Jones C.M., Brooks A.G., Cameron P.U., Heath W.R., and Carbone F.R. Virus infection expands a biased subset of T cells that bind tetrameric class I peptide complexes. Eur. J. Immunol. 33 (2003) 1557-1567
7. de Jong M.D., and Hien T.T. Avian influenza A (H5N1). J. Clin. Virol. 35 (2006) 2-13
8. Dillon S.B., Demuth S.G., Schneider M.A., Weston C.B., Jones C.S., Young J.F., Scott M., Bhatnaghar P.K., LoCastro S., and Hanna N. Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant. Vaccine 10 (1992) 309-318
9. Ennis P.D., Jackson A.P., and Parham P. Molecular cloning of bovine class I MHC cDNA. J. Immunol. 141 (1988) 642-651
10. Erf G.F., Bottje W.G., and Bersi T.K. CD4, CD8 and TCR defined T-cell subsets in thymus and spleen of 2- and 7-week old commercial broiler chickens. Vet. Immunol. Immunopathol. 62 (1998) 339-348
11. Gao G.F., Tormo J., Gerth U.C., Wyer J.R., McMichael A.J., Stuart D.I., Bell J.I., Jones E.Y., and Jakobsen B.K. Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2. Nature 387 (1997) 630-634
12. Garboczi D.N., Ghosh P., Utz U., Fan Q.R., Biddison W.E., and Wiley D.C. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384 (1996) 134-141
13. Green N., Alexander H., Olson A., Alexander S., Shinnick T.M., Sutcliffe J.G., and Lerner R.A. Immunogenic structure of the influenza virus hemagglutinin. Cell 28 (1982) 477-487
14. Grotenbreg G.M., Roan N.R., Guillen E., Meijers R., Wang J.H., Bell G.W., Starnbach M.N., and Ploegh H.L. Discovery of CD8+ T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramers. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 3831-3836
15. Hachinohe S., Sugawara K., Nishimura H., Kitame F., and Nakamura K. Effect of anti-haemagglutinin-esterase glycoprotein monoclonal antibodies on the receptor-destroying activity of influenza C virus. J. Gen. Virol. 70 Pt 5 (1989) 1287-1292
16. Horton R.M., Hunt H.D., Ho S.N., Pullen J.K., and Pease L.R. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77 (1989) 61-68
17. Kaufman J., Andersen R., Avila D., Engberg J., Lambris J., Salomonsen J., Welinder K., and Skjodt K. Different features of the MHC class I heterodimer have evolved at different rates. Chicken B-F and beta 2-microglobulin sequences reveal invariant surface residues. J. Immunol. 148 (1992) 1532-1546
18. Kaufman J., Jacob J., Shaw I., Walker B., Milne S., Beck S., and Salomonsen J. Gene organisation determines evolution of function in the chicken MHC. Immunol. Rev. 167 (1999) 101-117
19. Kaufman J., Milne S., Gobel T.W., Walker B.A., Jacob J.P., Auffray C., Zoorob R., and Beck S. The chicken B locus is a minimal essential major histocompatibility complex. Nature 401 (1999) 923-925
20. Kievits F., Ivanyi P., Krimpenfort P., Berns A., and Ploegh H.L. HLA-restricted recognition of viral antigens in HLA transgenic mice. Nature 329 (1987) 447-449
21. Kline K., Briles W.E., Bacon L., and Sanders B.G. Characterization of different B-F (MHC class I) molecules in the chicken. J. Hered. 79 (1988) 239-248
22. Koch M., Camp S., Collen T., Avila D., Salomonsen J., Wallny H.J., van Hateren A., Hunt L., Jacob J.P., Johnston F., Marston D.A., Shaw I., Dunbar P.R., Cerundolo V., Jones E.Y., and Kaufman J. Structures of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding. Immunity 27 (2007) 885-899
23. Kuzushima K., Hayashi N., Kimura H., and Tsurumi T. Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8(+) T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay. Blood 98 (2001) 1872-1881
24. Li X.S., Fang Q.M., Yan R.Q., Gao F.S., Hao H.F., Jia Z.H., Lin C.Y., and Xia C. Extensive analysis of different allelelic structures of the chicken BF2 and beta2m proteins. Vet. Immunol. Immunopathol. 113 (2006) 215-223
25. Li Z.D., and Yeh M. Construction and diversity analysis of a murine IgE phage surface display library. Cell Res. 7 (1997) 161-170
26. Liu G., Wang Q., Tong T., Xiao Y., Bai Y., Liu S., and Wu D. Construction and functional test of a chicken MHC-I (BF2*15)/peptide tetramer. Vet. Immunol. Immunopathol. 122 (2008) 1-7
27. Liu J., Xiao H., Lei F., Zhu Q., Qin K., Zhang X.W., Zhang X.L., Zhao D., Wang G., Feng Y., Ma J., Liu W., Wang J., and Gao G.F. Highly pathogenic H5N1 influenza virus infection in migratory birds. Science 309 (2005) 1206
28. Madden D.R., Garboczi D.N., and Wiley D.C. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75 (1993) 693-708
29. Mbawuike I.N., Dillion S.B., Demuth S.G., Jones C.S., Cate T.R., and Couch R.B. Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein. Vaccine 12 (1994) 1340-1348
30. Miller M.M., Goto R., Bernot A., Zoorob R., Auffray C., Bumstead N., and Briles W.E. Two Mhc class I and two Mhc class II genes map to the chicken Rfp-Y system outside the B complex. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 4397-4401
31. Mumford E., Bishop J., Hendrickx S., Embarek P.B., and Perdue M. Avian influenza H5N1: risks at the human-animal interface. Food. Nutr. Bull. 28 (2007) S357-363
32. Nagorsen, D., Thiel, E., 2008. HLA typing demands for peptide-based anti-cancer vaccine. Cancer Immunol. Immunother.
33. NEB, 1991-2001, pMAL Protein Fusion and Purification System Instruction Manual. New England Biolads Inc., Version 5.01, 3-33.
34. Okuno Y., Isegawa Y., Sasao F., and Ueda S. A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J. Virol. 67 (1993) 2552-2558
35. Savage P., Millrain M., Dimakou S., Stebbing J., and Dyson J. Expansion of CD8+ cytotoxic T cells in vitro and in vivo using MHC class I tetramers. Tumour Biol. 28 (2007) 70-76
36. Seo S.H., Peiris M., and Webster R.G. Protective cross-reactive cellular immunity to lethal A/Goose/Guangdong/1/96-like H5N1 influenza virus is correlated with the proportion of pulmonary CD8(+) T cells expressing gamma interferon. J. Virol. 76 (2002) 4886-4890
37. Seo S.H., and Webster R.G. Cross-reactive, cell-mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets. J. Virol. 75 (2001) 2516-2525
38. Shapira M., Jibson M., Muller G., and Arnon R. Immunity and protection against influenza virus by synthetic peptide corresponding to antigenic sites of hemagglutinin. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 2461-2465
39. Smirnov Iu A., Lipatov A.S., Okuno I., and Gitel'man A.K. A common antigenic epitope in influenza A virus (H1, H2, H5, H6) hemagglutinin. Vopr. Virusol. 44 (1999) 111-115
40. Storkus W.J., Zeh III H.J., Maeurer M.J., Salter R.D., and Lotze M.T. Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes. J. Immunol. 151 (1993) 3719-3727
41. Sylvester-Hvid C., Nielsen L.L., Hansen N.J., Pedersen L.O., and Buus S. A single-chain fusion molecule consisting of peptide, major histocompatibility gene complex class I heavy chain and beta2-microglobulin can fold partially correctly, but binds peptide inefficiently. Scand. J. Immunol. 50 (1999) 355-362
42. Walker E.B., Haley D., Miller W., Floyd K., Wisner K.P., Sanjuan N., Maecker H., Romero P., Hu H.M., Alvord W.G., Smith II J.W., B A.F., and Urba W.J. gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cells. Clin. Cancer Res. 10 (2004) 668-680
43. Wang B., Chen H., Jiang X., Zhang M., Wan T., Li N., Zhou X., Wu Y., Yang F., Yu Y., Wang X., Yang R., and Cao X. Identification of an HLA-A*0201-restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein. Blood 104 (2004) 200-206
44. Weichold F.F., Mueller S., Kortsik C., Hitzler W.E., Wulf M.J., Hone D.M., Sadoff J.C., and Maeurer M.J. Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosis. Genes Immun. 8 (2007) 334-343
45. Whelan J.A., Dunbar P.R., Price D.A., Purbhoo M.A., Lechner F., Ogg G.S., Griffiths G., Phillips R.E., Cerundolo V., and Sewell A.K. Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent. J. Immunol. 163 (1999) 4342-4348
46. Willcox B.E., Thomas L.M., and Bjorkman P.J. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat. Immunol. 4 (2003) 913-919
47. Xia C., Dan W., Wen-Xue W., Jian-Qing W., Li W., Tian-Yao Y., Qin W., and Yi-Bao N. Cloning and expression of interferon-alpha/gamma from a domestic porcine breed and its effect on classical swine fever virus. Vet. Immunol. Immunopathol. 104 (2005) 81-89
48. Xu X.N., and Screaton G.R. MHC/peptide tetramer-based studies of T cell function. J. Immunol. Methods 268 (2002) 21-28
49. Yan R.Q., Li X.S., Yang T.Y., and Xia C. Characterization of BF2 and beta2m in three Chinese chicken lines. Vet. Immunol. Immunopathol. 108 (2005) 417-425
50. Yan R.Q., Li X.S., Yang T.Y., and Xia C. Structures and homology modeling of chicken major histocompatibility complex protein class I (BF2 and beta2m). Mol. Immunol. 43 (2006) 1040-1046
51. Yano A., Onozuka A., Asahi-Ozaki Y., Imai S., Hanada N., Miwa Y., and Nisizawa T. An ingenious design for peptide vaccines. Vaccine 23 (2005) 2322-2326